The SI-ROBOTICS project aims to conceive and develop new solutions in the field of ICT assistive robotic technologies to support the provision of healthcare services. The scientific objective of SI-ROBOTICS is to design and implement easily adaptable technological solutions to help the elderly in their daily activities and to assess the progress of their physical and cognitive decline (fragility, dementia, mild cognitive impairment). This makes it possible to identify specific challenges for early diagnosis, objective assessment, therapy control and rehabilitation. Innovative robotics concepts and solutions will be introduced to anticipate user needs and provide assistance, monitoring and coaching.
The aim of the INSTAMED project is to create an integrated hardware and software platform for standardization and advanced automation, through IoT (Internet of Things) and / or CPS (Cyber-Physical Systems) technologies, of the processes of diagnosis, care and surgical treatment with a personalized medicine perspective.
The BIOMIS project envisages the establishment of the first Italian biobank of intestinal microbiota and human saliva with the aim of carrying out research activities aimed at identifying the relationships between microbiota and pathologies and testing innovative therapeutic approaches involving the transplantation of human microbiota in patients affected by specific diseases in order to modulate the patients' microbiota and restore the healthy one.
“Big Data” and imaging genomics for the development of innovative biomarkers and nanovector drugs to diagnose and treat inflammatory processes in dementia BigImAGING.
Neuroscience, equipped with the tools of Data Science and AI, today plays a fundamental role, particularly in research on Alzheimer's disease, the most widespread and disabling neurodegenerative disease for which, to date, there is no cure. A great challenge is that of early diagnosis, which represents an important goal in the perspective of testing new drugs.
Download the Paper delivered through the collaboration between Exprivia and the Universidad de Zaragoza.
